Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-09-29

Clinical Trial Update: Neuroinflammation in Hypertension Study [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update on neuroinflammation in hypertension, focusing on resistant hypertension; status unspecified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Royal Perth Hospital | Conditions: Resistant Hypertension | Phase 3 | Status: UNKNOWN